Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,7,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,73.3433,%,8.5281,22.5631,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48296,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,84.035,%,4.2158,12.6474,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48300,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,female,63 days to 49 days,8,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,106.215,%,10.5053,29.7136,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48407,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart pumping trait,Moms and pups used in studies were fed Teklad,RS:0000337,FHH-Chr 8BN/Mcwi,male,63 days to 49 days,9,,CMO:0000742,percent change in heart rate,post-ischemic value/pre-ischemic value x 100%,,,102.1873,%,12.3276,36.9828,MMO:0000029,balloon tipped catheter with pressure transducer in isolated perfused heart,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),48411,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours),